Lifecore Biomedical Inc (LFCR)
5.87
+0.10
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Lifecore Biomedical Revenue (Quarterly): 31.55M for May 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | 25.52M |
| February 28, 2023 | 27.60M |
| November 30, 2022 | 38.80M |
| August 31, 2022 | 43.36M |
| May 31, 2022 | 21.13M |
| February 28, 2022 | 37.40M |
| November 30, 2021 | 43.45M |
| August 31, 2021 | 41.63M |
| May 31, 2021 | -25.76M |
| February 28, 2021 | 44.69M |
| November 30, 2020 | 130.90M |
| August 31, 2020 | 135.64M |
| May 31, 2020 | -274.17M |
| February 29, 2020 | 152.93M |
| November 30, 2019 | 142.59M |
| August 31, 2019 | 138.71M |
| May 31, 2019 | 152.78M |
| February 28, 2019 | 155.55M |
| November 30, 2018 | 124.56M |
| August 31, 2018 | 124.67M |
| May 31, 2018 | 141.08M |
| February 28, 2018 | 144.91M |
| November 30, 2017 | 122.46M |
| August 31, 2017 | 115.78M |
| May 31, 2017 | 64.95M |
| Date | Value |
|---|---|
| February 28, 2017 | 136.57M |
| November 30, 2016 | 135.86M |
| August 31, 2016 | 132.39M |
| May 31, 2016 | 71.13M |
| February 29, 2016 | 129.99M |
| November 30, 2015 | 140.44M |
| August 31, 2015 | 135.36M |
| May 31, 2015 | 134.45M |
| February 28, 2015 | 138.53M |
| November 30, 2014 | 132.66M |
| August 31, 2014 | 133.61M |
| May 31, 2014 | 120.93M |
| February 28, 2014 | 126.38M |
| November 30, 2013 | 120.03M |
| August 31, 2013 | 109.48M |
| May 31, 2013 | 107.11M |
| February 28, 2013 | 117.87M |
| November 30, 2012 | 114.65M |
| August 31, 2012 | 102.07M |
| May 31, 2012 | 82.62M |
| February 29, 2012 | 80.06M |
| November 30, 2011 | 81.57M |
| August 31, 2011 | 73.30M |
| May 31, 2011 | 68.10M |
| February 28, 2011 | 73.51M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-274.17M
Minimum
May 2020
152.93M
Maximum
Feb 2020
51.60M
Average
43.36M
Median
Aug 2022
Revenue (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 12.05M |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | 81.88M |
| Relmada Therapeutics Inc | -- |
| Jaguar Health Inc | 2.351M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.13M |
| Total Expenses (Quarterly) | 36.96M |
| EPS Diluted (Quarterly) | -1.19 |